AustralianSuper Pty Ltd trimmed its position in Cigna Group (NYSE:CI – Free Report) by 16.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 89,001 shares of the health services provider’s stock after selling 17,698 shares during the period. AustralianSuper Pty Ltd’s holdings in Cigna Group were worth $24,496,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently bought and sold shares of CI. Beacon Financial Strategies CORP acquired a new stake in Cigna Group in the fourth quarter worth about $28,000. Lodestone Wealth Management LLC acquired a new stake in Cigna Group in the fourth quarter worth about $32,000. Collier Financial acquired a new stake in Cigna Group in the third quarter worth about $34,000. Activest Wealth Management increased its position in Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after purchasing an additional 126 shares during the period. Finally, True Wealth Design LLC raised its stake in shares of Cigna Group by 116.4% during the fourth quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock worth $43,000 after buying an additional 85 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on CI. Truist Financial boosted their price target on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. Wells Fargo & Company boosted their price target on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. UBS Group reissued a “buy” rating and issued a $375.00 price target on shares of Cigna Group in a research note on Monday, February 9th. Raymond James Financial set a $340.00 price target on Cigna Group in a research note on Friday, May 1st. Finally, TD Cowen increased their price target on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $338.35.
Cigna Group Stock Down 3.3%
Shares of NYSE CI opened at $285.25 on Friday. The stock has a market cap of $75.46 billion, a P/E ratio of 12.09, a P/E/G ratio of 1.03 and a beta of 0.30. The firm has a 50 day moving average price of $274.95 and a 200 day moving average price of $275.97. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts expect that Cigna Group will post 30.39 EPS for the current year.
Cigna Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is currently 26.45%.
Insider Activity at Cigna Group
In other news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 205,904 shares of company stock worth $60,277,068 in the last quarter. Corporate insiders own 0.60% of the company’s stock.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
